Trials / Recruiting
RecruitingNCT06234501
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Reading · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Detailed description
The main question it aims to answer is: * Does high-dose Vitamin B6 supplementation reduce sensory hyperreactivity differences in autism? * Does high-dose Vitamin B6 supplementation reduce anxiety differences in autism? * Explore the effects of vitamin B6 on sleep quality, Attention Deficit Hyperactivity Disorder (ADHD) scores, and various visual perception tasks that are indicative of GABAergic activity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pyridoxal 5'-Phosphate (100 mg) | 100 mg Pyridoxal 5'-Phosphate tablet once daily with food |
| OTHER | Placebo | Placebo tablet once daily |
Timeline
- Start date
- 2024-11-08
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2024-01-31
- Last updated
- 2026-03-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06234501. Inclusion in this directory is not an endorsement.